BIOMAT Database Logo BIOMAT Database Logo

Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals. 2023

Alexander Batista-Duharte, and Salvador F Aliño
Immunology and Allergy Group (GC01), Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Reina Sofia University Hospital, Cordoba, Spain.

UI MeSH Term Description Entries

Related Publications

Alexander Batista-Duharte, and Salvador F Aliño
Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy.
September 2020, Journal of the National Comprehensive Cancer Network : JNCCN,
Alexander Batista-Duharte, and Salvador F Aliño
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls.
March 2020, Current oncology reports,
Alexander Batista-Duharte, and Salvador F Aliño
[Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)].
June 2021, Bulletin du cancer,
Alexander Batista-Duharte, and Salvador F Aliño
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management.
January 2024, Pharmaceutical medicine,
Alexander Batista-Duharte, and Salvador F Aliño
Diagnosis and Management of Immune Related Adverse Events (irAEs) in Cancer Immunotherapy.
December 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Alexander Batista-Duharte, and Salvador F Aliño
Focus on immune-related adverse events (irAEs) in immunotherapy of hepatobiliary malignancies.
June 2020, Hepatobiliary surgery and nutrition,
Alexander Batista-Duharte, and Salvador F Aliño
[Management of immune-related adverse events (irAEs) - what needs to be respected?]
January 2022, Der Gynakologe,
Alexander Batista-Duharte, and Salvador F Aliño
Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.
September 2023, Immunological reviews,
Alexander Batista-Duharte, and Salvador F Aliño
Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors.
July 2023, Current oncology (Toronto, Ont.),
Alexander Batista-Duharte, and Salvador F Aliño
Association between skin immune-related adverse events (irAEs) and multisystem irAEs during PD-1/PD-L1 inhibitor monotherapy.
April 2023, Journal of cancer research and clinical oncology,
Copied contents to your clipboard!